Ketamine therapy has become an increasingly popular treatment option for depression, but how successful is it? Recent studies have shown that ketamine therapy can be a very effective treatment for those with severe depression. It has been found to quickly reduce symptoms and is even used as a rapid antidepressant. A 2020 study published in The Lancet Psychiatry found that two ketamine sessions over two weeks significantly improved depressive symptoms among participants over the course of one month.
In addition, other research suggests that ketamine therapy can benefit specific individuals with treatment-resistant depression, bipolar depression, and post-traumatic stress disorder. A 2018 study published in Frontiers in Psychiatry found that five sessions of ketamine resulted in improvement in 38% of treatment-resistant depression patients and 48% of bipolar depression patients over a period of three months. Similarly, a 2019 paper found ketamine to help reduce PTSD symptoms.
Despite its potential benefits, it’s important to note that ketamine has not been approved by the FDA for treating any psychiatric condition; however, some providers use it off-label as a treatment option for specific conditions. Therefore, if you are considering trying ketamine therapy for depression, anxiety, or other mental health conditions, it is essential to talk to a mental health provider about the potential risks and their possible benefits.
Overall, research indicates that ketamine therapy can be an effective treatment option for some people with depression, anxiety, PTSD, substance abuse disorders, or other mental health conditions – especially those who have not responded to traditional treatments such as medications or psychotherapy. While further studies are needed and continue to fully understand its long-term safety and efficacy, ketamine does appear to provide symptom relief within days or even hours rather than weeks or months, as many other antidepressants do.